Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children WHO Headquarters, Geneva, Switzerland

Size: px
Start display at page:

Download "Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children WHO Headquarters, Geneva, Switzerland"

Transcription

1 Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children WHO Headquarters, Geneva, Switzerland Comments of the Malta Chamber of Pharmacists 15 th February 2008 The Malta Chamber of Pharmacists welcomes the report of the WHO of the Informal Expert Meeting on Dosage Forms of Medicines for Children. The Chamber is aware of the problems, caregivers and parents face when administering medicines to their children and also aware of the lack of appropriate pediatric dosage forms that health care processionals, including pharmacists encounter when dispensing or prescribing medicines to children. This is further compounded by scarcity of research and lack of details of the dose (and age related dose) of paediatric medicines. Last year the EU finalised a directive on research in children and hopefully in the future there will be more information as regards the safety and appropriate dose of paediatric medicines. This will enable better access to safe, effective and appropriate treatment and contribute to decrease mortality and morbidity rates within this age group. Situation in Malta There is a discrepancy in the availability of suitable medicines for children when compared to those available for adults. The rectal route of administration is a preferred route in neonates, due to ease of administration. It is mostly used for the administration of analgesics, ant emetics and steroids. However this route becomes a problem as children gets older. Chewable tablets are usually a preferred dosage form to syrups in the case of vitamin preparations. Palatability of medicines treatments. poses a problem in administering certain Examples include reconstituted antibiotic suspensions, dehydration salts, dispersible tablets and cough syrups. reconstituted oral Priority medicines for which no dosage form for children currently exists include treatment of epilepsy and systemic antifungals ( eg Grisofulvin). There is also the problem of adequate dosage forms to administer systemic steroids to children during an acute attack of asthma, bronchitis or croup.

2 Off label medicine use of certain treatments is also an area of concern. An important aspect is timing of administration of the treatment. It is important to consider that medicines are usually administered in the morning prior to a child goes to school, afternoon when they return from school or before they go to bed. A twice daily dosage or a single daily dose will influence adherence to treatment. The price of metered dose inhalers, and other devises for use by asthmatic patients and dispersible tablets are a deterrent, as many people find them too expensive Desirable attributes of a paediatric dosage form The Chamber aggress with the points raised as regards desirable attributes of a paediatric dosage form and highlights the need for novel dosage forms to take into consideration the: ease of administration, (ease of giving appropriate dose and the ability to reliably divide the unit dose) price, acceptability by children and caregivers. Package insert which is caregiver and children friendly (in case of older children). Studies carried in Malta identified the use of pictograms to aid administration of medicines. Welcome the proposals made in this report for developments of dosage forms and for research. An area which needs to be also address is Diabetes. Whilst acknowledging that a lot of research has been done in this area, it is noted that paediatric patients do encounter hypoglycaemic problems with current insulin treatment and the frequent monitoring poses problems.. Additionally notwithstanding the use of the pen an alternates route of administration to the SC route can improve considerable their quality of life. The problem increases once children gets older. Epilepsy is also an area which needs to be given more attention so that children will enjoy a good quality of life. The Chamber welcomes this report and would like to see the CPA represented on the committee of WHO to address this important matter. Mary Anne Ciappara

3

4

5

6

7

8

9

Anatomical Therapeutic Chemical Classification (ATC) & And Defined Daily Dose (DDD) Principles for classifying and quantifying drug use

Anatomical Therapeutic Chemical Classification (ATC) & And Defined Daily Dose (DDD) Principles for classifying and quantifying drug use Anatomical Therapeutic Chemical Classification (ATC) & And Defined Daily Dose (DDD) Principles for classifying and quantifying drug use Margaret Oluka Course outline/objectives 1. Introduction: drug classification

More information

Sources and Prices of Medicines for Children.

Sources and Prices of Medicines for Children. Sources and Prices of Medicines for Children. Consultation on Priority Essential Medicines for Child Survival 6th-7th September, 2010 Copenhagen, Denmark 1 Sources and Prices of Selected Medicines for

More information

Background. Methods. Study Objectives. Methods - 2. Pilot Study

Background. Methods. Study Objectives. Methods - 2. Pilot Study Current Administration Practices and Preferred Formulations of s Medicines in Tanzania Background 8.1 million child deaths / year Lack of pediatric formulations for many medicines to treat common illnesses

More information

Guidance on Bulk Prescribing for Care Home Residents

Guidance on Bulk Prescribing for Care Home Residents Guidance on Bulk Prescribing for Care Home Residents There are many residents in care homes taking medicines when required, which may present problems for the prescriber in determining the quantity to

More information

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010 Priority essential medicines: identifying products Dr Suzanne Hill September 2010 The problem looks like this Robertson, Forte, Trapsida & Hill. Bull WHO 2009 Robertson, Forte, Trapsida & Hill. Bull WHO

More information

Industry Perspective on Formulation and Packaging Considerations

Industry Perspective on Formulation and Packaging Considerations Industry Perspective on Formulation and Packaging Considerations Ron Ogilvie (Pfizer) EFPIA February 2012 1 Industry Perspective on Formulation and Packaging Considerations Provide an overview of formulation

More information

International initiatives on extemporaneous dispensing

International initiatives on extemporaneous dispensing Partners meeting WHO, Geneva 21 22 November 2011 International initiatives on extemporaneous dispensing Tony Nunn and Mark Turner UK Medicines for Children Research Network University of Liverpool Industry

More information

In 2002, it was reported that 72 of 1000

In 2002, it was reported that 72 of 1000 REPORTS Aligning Patient Care and Asthma Treatment Guidelines Eric Cannon, PharmD Abstract This article describes how the National Asthma Education and Prevention Program Guidelines for the Diagnosis and

More information

CODE OF PRACTICE ADMINISTRATION OF MEDICINES POLICY AND MEDICINES PROTOCOL

CODE OF PRACTICE ADMINISTRATION OF MEDICINES POLICY AND MEDICINES PROTOCOL CODE OF PRACTICE ADMINISTRATION OF MEDICINES POLICY AND MEDICINES PROTOCOL Aims To ensure the appropriate and safe administration of medication to students while at school. To ensure the safe storage of

More information

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation

Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation Completion of the development of a formulation: Requirements for compliance check vs. requirements for Marketing Authorisation Workshop on Paediatric Formulations For Assessors in National Regulatory Agencies

More information

Asthma Medications: Information for Children and Families. What You Need to Know about Medicines for Asthma

Asthma Medications: Information for Children and Families. What You Need to Know about Medicines for Asthma Page 1 of 8 PED-ALL-005-1992 Asthma Medications: Information for Children and Families What You Need to Know about Medicines for Asthma What Medicines Are used to Treat Asthma? There are two kinds of medicines:

More information

Swiss Summary of the Risk Management Plan (RMP) for Nucala (Mepolizumab)

Swiss Summary of the Risk Management Plan (RMP) for Nucala (Mepolizumab) Swiss Summary of the Risk Management Plan (RMP) for Nucala (Mepolizumab) RMP Summary: Version 1, March 2017 EU RMP: Version 2, 26.5.2016 The Risk Management Plan (RMP) is a comprehensive document submitted

More information

Clinical Impact of Pharmaceutical Care Services in Pediatric and Neonatal Intensive Care Unit. Amanda Li Clinical Pharmacist Queen Mary Hospital

Clinical Impact of Pharmaceutical Care Services in Pediatric and Neonatal Intensive Care Unit. Amanda Li Clinical Pharmacist Queen Mary Hospital Clinical Impact of Pharmaceutical Care Services in Pediatric and Neonatal Intensive Care Unit Amanda Li Clinical Pharmacist Queen Mary Hospital Patient Safety Error pattern unique to the specialty 3 times

More information

Safe, effective, affordable drug choices: online tool for payers and patients.

Safe, effective, affordable drug choices: online tool for payers and patients. Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

beclometasone 100 MDI 2 puffs twice a day (recently changed to non CFC (Clenil Modulite))

beclometasone 100 MDI 2 puffs twice a day (recently changed to non CFC (Clenil Modulite)) Case 1 Mr Thomson, a 32 year old asthmatic who is well known to you comes into your pharmacy. He is known to have a best peak flow of 640 L/min. He tells you that over the last few weeks he has been wakening

More information

Guideline on pharmaceutical development of medicines for paediatric use

Guideline on pharmaceutical development of medicines for paediatric use 1 2 3 4 3 January 2013 EMA/CHMP/QWP/805880/2012 Rev. 1 Committee for Medicinal Products for Human Use (CHMP) Paediatric Committee (PDCO) 5 6 7 Guideline on pharmaceutical development of medicines for paediatric

More information

Fixed Dose Combination a Simplified Approach to Pediatric Antiretroviral Treatment

Fixed Dose Combination a Simplified Approach to Pediatric Antiretroviral Treatment Fixed Dose Combination a Simplified Approach to Pediatric Antiretroviral Treatment Dr. David Pugatch Clinton Foundation Phnom Penh, Cambodia February, 2007 Lecture Goals To introduce and define fixed dose

More information

ASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009

ASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009 This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN

More information

Diabetes Subcommittee of PTAC meeting held 3 March (minutes for web publishing)

Diabetes Subcommittee of PTAC meeting held 3 March (minutes for web publishing) Diabetes Subcommittee of PTAC meeting held 3 March 2011 (minutes for web publishing) Diabetes Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics

More information

HARRISON COUNTY SCHOOLS OFFICE OF HEALTH SERVICES 445 W. Main Street Clarksburg, WV (304) FAX (304)

HARRISON COUNTY SCHOOLS OFFICE OF HEALTH SERVICES 445 W. Main Street Clarksburg, WV (304) FAX (304) HARRISON COUNTY SCHOOLS OFFICE OF HEALTH SERVICES 44 W. Main Street Clarksburg, WV 6 (4) 6-769 FAX (4) 6-769 Dear Parent, Date Please complete the enclosed forms and return them to your school nurse. This

More information

Care Homes - Homely Remedies Protocol

Care Homes - Homely Remedies Protocol Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained

More information

Formulation factors affecting acceptability of oral medicines in children

Formulation factors affecting acceptability of oral medicines in children 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Formulation factors affecting acceptability of oral medicines in children Fang Liu 1*, Sejal Ranmal 2, Hannah K. Batchelor 3, Mine Orlu-Gul 2, Terry B. Ernest

More information

FREEDOM OF INFORMATION SUMMARY S/NADA Pfizer Inc 235 East 42 nd Street New York, New York 10017

FREEDOM OF INFORMATION SUMMARY S/NADA Pfizer Inc 235 East 42 nd Street New York, New York 10017 Approved: Nov 26 2001 FREEDOM OF INFORMATION SUMMARY Rimadyl (carprofen) Chewable Tablets for Dogs S/NADA 141-111 Pfizer Inc 235 East 42 nd Street New York, New York 10017 Table of Contents I. GENERAL

More information

Nephrotic Syndrome. Author: Paediatric Department Document Number: STHK0862 Version: 5 Review date: 30 June 2020 HELEN WINSTON

Nephrotic Syndrome. Author: Paediatric Department Document Number: STHK0862 Version: 5 Review date: 30 June 2020 HELEN WINSTON Nephrotic Syndrome WINSTON HELEN Author: Paediatric Department Document Number: STHK0862 Version: 5 Review date: 30 June 2020 Nature and reasons for the condition Nephrotic syndrome is a condition where

More information

Core Safety Profile. Pharmaceutical form(s)/strength: Dry Powder Inhaler, Nebuliser Suspension, pressurised Metered Dose Inhaler (pmdi)

Core Safety Profile. Pharmaceutical form(s)/strength: Dry Powder Inhaler, Nebuliser Suspension, pressurised Metered Dose Inhaler (pmdi) Core Safety Profile Active substance: Budesonide Pharmaceutical form(s)/strength: Dry Powder Inhaler, Nebuliser Suspension, pressurised Metered Dose Inhaler (pmdi) P - RMS: DK/H/PSUR/0041/001 Date of FAR:

More information

List of Optimal Paediatric Formulations. Marianne Gauval (CHAI) IAS-ILF Round table Geneva, Switzerland 26 November 2013

List of Optimal Paediatric Formulations. Marianne Gauval (CHAI) IAS-ILF Round table Geneva, Switzerland 26 November 2013 List of Optimal Paediatric Formulations Marianne Gauval (CHAI) IAS-ILF Round table Geneva, Switzerland 26 November 2013 1 History of development of treatment options for children Adult tablets Syrups and

More information

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply

More information

Artemether 20mg/lumefantrine 120mg WHOPAR part 5 12/2011 Dispersible tablets (Novartis Pharma AG), MA069 LABELLING. Page 1 of 6

Artemether 20mg/lumefantrine 120mg WHOPAR part 5 12/2011 Dispersible tablets (Novartis Pharma AG), MA069 LABELLING. Page 1 of 6 LABELLING Page 1 of 6 PARTICULARS TO APPEAR ON THE OUTER PACKAGE CARTON OF UNIT PACK 1. NAME OF THE MEDICINAL PRODUCT Coartem Dispersible Artemether/Lumefantrine 2. STATEMENT OF ACTIVE SUBSTANCE(S) Artemether

More information

Pharmacoeconomic Analysis of Asthma in Pediatric Patients in Tertiary Care Hospital in Kerala

Pharmacoeconomic Analysis of Asthma in Pediatric Patients in Tertiary Care Hospital in Kerala Indian Journal of Pharmacy Practice Association of Pharmaceutical Teachers of India Pharmacoeconomic Analysis of Asthma in Pediatric Patients in Tertiary Care Hospital in Kerala Stejin J*, Kishor KV, Nandha

More information

Questionnaire Survey for Bronchial Asthma in Elderly Care Facilities

Questionnaire Survey for Bronchial Asthma in Elderly Care Facilities Kobe J. Med. Sci., Vol. 64, No. 5, pp. E174-E179, 2018 Questionnaire Survey for Bronchial Asthma in Elderly Care Facilities HARUKO SHINKE 1, HIROSHI KAMIRYO 1, KANOKO UMEZAWA 1, SUYA HORI 1, KYOSUKE NAKATA

More information

Extra strong and highly concentrated *

Extra strong and highly concentrated * Cough? Bronchitis? Bronchipret soothes the cough releases the blocked mucus combats the inflammation in the bronchial tubes Extra strong and highly concentrated * * extra strong in relation to the total

More information

SIOFOR mg film-coated tablets

SIOFOR mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SIOFOR 850 850mg film-coated tablets METFORMIN HYDROCHLORIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for

More information

National Diabetes Inpatient Audit (NaDIA) 2016

National Diabetes Inpatient Audit (NaDIA) 2016 National Diabetes Inpatient Audit (NaDIA) 2016 DIABETES A summary report for people with diabetes and anyone interested in the quality of care for people with diabetes when they stay in hospital. Based

More information

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

Paediatric Prescribing Pocket Guide September 2014 (Version 1) PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors

More information

Nucala. Nucala (mepolizumab) Description

Nucala. Nucala (mepolizumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.07 Subject: Nucala Page: 1 of 5 Last Review Date: December 2, 2016 Nucala Description Nucala (mepolizumab)

More information

GUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003

GUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003 EUROPN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, implementation and legislation for consumer goods Pharmaceuticals : regulary framework and market authorisations Brussels, F2/AW D(2002)

More information

HOLY FAMILY CATHOLIC SCHOOL MEDICATION AND ASTHMA POLICY

HOLY FAMILY CATHOLIC SCHOOL MEDICATION AND ASTHMA POLICY HOLY FAMILY CATHOLIC SCHOOL MEDICATION AND ASTHMA POLICY Policy Statement - We would ask parents to request that their doctor, wherever possible, prescribe medication, which can be taken outside the school

More information

SIOFOR mg film-coated tablets

SIOFOR mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SIOFOR 1000 1000mg film-coated tablets For use in children from 10 years and adults METFORMIN HYDROCHLORIDE This leaflet is a copy of the Summary of Product Characteristics

More information

SINGULAIR JUNIOR 5mg chewable tablets

SINGULAIR JUNIOR 5mg chewable tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SINGULAIR JUNIOR 5mg chewable tablets MONTELUKAST This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely

More information

Asthma Policy. Mrs Freame and Mrs Cicco are Asthma Lead Professionals at Bromham Primary School and have attended training in April 2017.

Asthma Policy. Mrs Freame and Mrs Cicco are Asthma Lead Professionals at Bromham Primary School and have attended training in April 2017. Asthma Policy Reviewed: May 2018 Date of next review: May 2021 For parents and school staff Statement of intent Bromham CofE Primary School welcomes children with asthma and tries to create a safe environment

More information

Package leaflet: Information for the user. Cinfalair Paediatric 4 mg Granules montelukast

Package leaflet: Information for the user. Cinfalair Paediatric 4 mg Granules montelukast Package leaflet: Information for the user Cinfalair Paediatric 4 mg Granules montelukast Read all of this leaflet carefully before you give this medicine to your child because it contains important information.

More information

Medication Administration Curriculum INSTRUCTOR S MANUAL. Name State Date

Medication Administration Curriculum INSTRUCTOR S MANUAL. Name State Date Instructions: Circle the letter of the choice that best completes the statement or answers the question. If select modules were presented, only fill out the questions related to those modules. MODULE 1

More information

Assessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form

Assessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form 38 East and Central African Journal of Pharmaceutical Sciences Vol. 15 (2012) 38-46 Assessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form N.N.

More information

Analysis of price discrepancies and its impact on rational use of medicines

Analysis of price discrepancies and its impact on rational use of medicines [Downloaded free from http://www.sudanmedicalmonitor.org on Tuesday, December 02, 2014, IP: 41.234.35.127] Click here to download free Android applica Original Article Analysis of price discrepancies and

More information

All Saints First School Administering of Medicines Policy

All Saints First School Administering of Medicines Policy All Saints First School Administering of Medicines Policy Success Indicators The following indicators will demonstrate the level of compliance with this policy and its procedures: a) Employees who are

More information

Package leaflet: Information for the user. Cinfalair 4 mg chewable tablets montelukast

Package leaflet: Information for the user. Cinfalair 4 mg chewable tablets montelukast Package leaflet: Information for the user Cinfalair 4 mg chewable tablets montelukast Read all of this leaflet carefully before you give this medicine to your child because it contains important information.

More information

PGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

PGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne Public consultation on Delegated Act on Post-Authorisation efficacy studies PGEU RESPONSE INTRODUCTION The Pharmaceutical Group of the European Union (PGEU) is the association representing community pharmacists

More information

PACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP

PACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP PACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP Brand or Product Name [Product name] Tablet 2mg [Product name] Tablet 4mg [Product name] Syrup 2mg/5ml Name and Strength of Active Substance(s)

More information

Medicines Improve your Understanding and your Health

Medicines Improve your Understanding and your Health Medicines Improve your Understanding and your Health Lung Health Patient Education Day 2015 Marina Lyne Pharmacist, Launceston General Hospital What we will discuss Medicines how they work Potential interactions

More information

Re: Inhaled insulin for the treatment of type 1 and type 2 diabetes comments on the Assessment Report for the above appraisal

Re: Inhaled insulin for the treatment of type 1 and type 2 diabetes comments on the Assessment Report for the above appraisal Dear Alana, Re: Inhaled insulin for the treatment of type 1 and type 2 diabetes comments on the Assessment Report for the above appraisal Thank you for allowing the Association of British Clinical Diabetologists

More information

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Ca-C 1000 Calvive 1000 mg + 327 mg + 1000 mg effervescent tablets CALCIUM LACTATE GLUCONATE, CALCIUM CARBONATE, ASCORBIC ACID (VITAMIN C) This leaflet is a copy

More information

The pathway to better medicines for children

The pathway to better medicines for children The pathway to better medicines for children As the World Health Organization counts down to 2015 and the Millennium Development Goal to reduce under five-year-old mortality by two-thirds, we reflect on

More information

2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64)

2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64) 2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Patient Insured - Traditional

More information

bpac better e m dicine

bpac better e m dicine INR Testing Quiz Feedback bpac nz better medicin e Contents INR Testing Quiz 2 Quiz Feedback: Responses from Colleagues, and Expert Review 4 bpac nz Review : Dr Janine Bailey, Motueka Dr Stephen Kuzmich,

More information

EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE

EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE The Fijian Government invites expressions of interest from reputable Manufacturers and Suppliers for the supply

More information

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA Harmonization effort for OTC monograph in Taiwan Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA Outline Background OTC drug registration OTC monographs Future directions

More information

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs page 1 CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs 2011 The following categories are included in this work programme: 1. Medicines

More information

Drug Prescribing. Ravi Menon

Drug Prescribing. Ravi Menon Drug Prescribing Ravi Menon Introduction Approximately 7,000 individual drug doses are administered each day in a 'typical' NHS hospital, 70% of which are prescribed by first year graduates and senior

More information

ASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12

ASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12 North Hampshire CCG Asthma Prescribing Guidelines June 2015 ASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12 These guidelines are based on the British Thoracic Society (BTS) and Scottish Intercollegiate

More information

Setting The setting was the community. The economic study was carried out in New Jersey, USA.

Setting The setting was the community. The economic study was carried out in New Jersey, USA. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy Luskin A, Bukstein D, Kocevar V S, Yin D D Record Status This

More information

Life-cycle approach to error prevention an overview

Life-cycle approach to error prevention an overview Life-cycle approach to error prevention an overview Kathryn Ord Unit Manager, Medicines and Healthcare products Regulatory Agency Information Day on Medication Errors 20 October 2016 London, UK Disclaimer

More information

Module 2: Vaccines and drugs: similarities and differences

Module 2: Vaccines and drugs: similarities and differences Module 2: Vaccines and drugs: similarities and differences Vaccine PV Fellowship WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance Accra, Ghana 7 th 18 th September 2015 Learning

More information

Guide to Interchangeable Medicines

Guide to Interchangeable Medicines Guide to Interchangeable Medicines AUT-G0115-6 01 JUNE 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1 BACKGROUND 3 1.1

More information

Flu is a more severe form of what people generally associate with as Cough, Cold and Fever and symptoms are usually incapacitating.

Flu is a more severe form of what people generally associate with as Cough, Cold and Fever and symptoms are usually incapacitating. SEASONAL HUMAN INFLUENZA (THE FLU) What is Seasonal Human Influenza? Seasonal Influenza is a viral infection that affects millions of people worldwide. It is transmitted from person to person through direct

More information

Calculations. Doses and Dosage Regimens. Pharmacy Technician Training Systems Passassured, LLC

Calculations. Doses and Dosage Regimens. Pharmacy Technician Training Systems Passassured, LLC Calculations Doses and Dosage Regimens Pharmacy Technician Training Systems Passassured, LLC Calculations, Doses and Dosage Regimens Calculations, Doses and Dosage Regimens Objectives Expressions of Dose

More information

CHARM ASTHMA TREATMENT GUIDELINE

CHARM ASTHMA TREATMENT GUIDELINE NHS City and Hackney Prescribing Guidelines Adults ( 12 years of age) CHARM ASTHMA TREATMENT GUIDELINE Written by: Hetal Dhruve (Specialist Respiratory Pharmacist, City and Hackney CCG) Checked by: Prof

More information

Chapter 2 is a general introduction to the drug administration

Chapter 2 is a general introduction to the drug administration Chapter 2 Safe and Accurate Drug Administration Chapter Overview Chapter 2 is a general introduction to the drug administration process. It introduces the student to the role of the person who administers

More information

Celecoxib Powder, Diclofenac Powder, Flurbiprofen Powder, Ibuprofen Powder, Ketoprofen Powder, Meloxicam Powder, Tramadol Powder

Celecoxib Powder, Diclofenac Powder, Flurbiprofen Powder, Ibuprofen Powder, Ketoprofen Powder, Meloxicam Powder, Tramadol Powder Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.26 Subject: Anti-Inflammatory Pain Powders Page: 1 of 5 Last Review Date: December 3, 2015 Anti-Inflammatory

More information

Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended.

Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended. Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Bricanyl () DK/W/0017/pdWS/001 Rapporteur: Denmark Finalisation procedure

More information

PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN

PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN Summary of Risk Management Plan for PREZISTA (Darunavir [TMC114]) This is a summary of the risk management plan (RMP) for PREZISTA. The RMP details important

More information

Insulin detemir (Levemir)... 2 Leuprorelin... 4 Levetiracetam (Keppra)... 5 Budesonide/eformoteral (Symbicort) widening access...

Insulin detemir (Levemir)... 2 Leuprorelin... 4 Levetiracetam (Keppra)... 5 Budesonide/eformoteral (Symbicort) widening access... August 2005 PTAC Meeting PTAC minutes are published in accordance with the following definitions from the PTAC Guidelines 2002: Minute means that part of the record of a PTAC or Sub-committee meeting (including

More information

Experience of paediatric formulations in Marketing Authorisatrion Applications

Experience of paediatric formulations in Marketing Authorisatrion Applications Experience of paediatric formulations in Marketing Authorisatrion Applications Elisabeth RICCHI Senior Quality Assessor 1 Overview of the presentation Formulation Measuring device Reconstitution packaging

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely remedy is a medicinal product

More information

LABELLING FOR DISPENSED PRODUCTS

LABELLING FOR DISPENSED PRODUCTS LABELLING FOR DISPENSED PRODUCTS Dr. Dhaivat C. Parikh Institute of Pharmacy, Nirma University DISCLAIMER This Presentation is Only for Internal Use. This Presentation is meant only for giving an overview

More information

AZITHROMYCIN 250 MG TREATMENT FOR TOOTHACHE PAIN RELIEF

AZITHROMYCIN 250 MG TREATMENT FOR TOOTHACHE PAIN RELIEF AZITHROMYCIN 250 MG TREATMENT FOR TOOTHACHE PAIN RELIEF Azithromycin 250 Mg Treatment For Toothache Pain Relief Seeing azithromycin 250 mg Azithromycin tablets ip 500 mg for acne Does azithromycin affect

More information

St. Jérôme Church of England Bilingual School. Asthma Policy. (September 2016) Executive Headteacher. Revd D. R. Norris

St. Jérôme Church of England Bilingual School. Asthma Policy. (September 2016) Executive Headteacher. Revd D. R. Norris St. Jérôme Church of England Bilingual School Asthma Policy (September 2016) Executive Headteacher. Revd D. R. Norris Chair of the Governing Body... Ian Fernandes Date:~ The school believes that the Asthma

More information

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid)

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid) PATIENT INFORMATION LEAFLET Nu-Seals 75 aspirin (acetylsalicylic acid) Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you

More information

CAN AZITHROMYCIN TREAT CANDIDA

CAN AZITHROMYCIN TREAT CANDIDA CAN AZITHROMYCIN TREAT CANDIDA Can Azithromycin Treat Candida Does azithromycin treat bronchitis Taking azithromycin on empty stomach Azithromycin and red wine What is the work of azithromycin tablets

More information

Ultrafiltration. A guide for patients undergoing ultrafiltration for the treatment of heart failure

Ultrafiltration. A guide for patients undergoing ultrafiltration for the treatment of heart failure Ultrafiltration A guide for patients undergoing ultrafiltration for the treatment of heart failure Dr Sue Ellery Consultant Cardiologist Patient Information What is heart failure? 3 What is the treatment

More information

The Importance of Treatment Compliance. Health Education Programme targeting the Elderly on the Correct Use of Medicines (PESGG)

The Importance of Treatment Compliance. Health Education Programme targeting the Elderly on the Correct Use of Medicines (PESGG) The Importance of Treatment Compliance Health Education Programme targeting the Elderly on the Correct Use of Medicines (PESGG) WHAT DOES PROPER USE OF MEDICINES MEAN? WHY DO WE NEED TO USE MEDICINES CORRECTLY?

More information

Proposal To reclassify Beconase Hayfever (beclomethasone 50 g/actuation) from Restricted Medicine to Pharmacy Medicine

Proposal To reclassify Beconase Hayfever (beclomethasone 50 g/actuation) from Restricted Medicine to Pharmacy Medicine Beconase Hayfever (Beclomethasone dipropionate, 50 per actuation) Proposal To reclassify Beconase Hayfever (beclomethasone 50 g/actuation) from Restricted Medicine to Pharmacy Medicine Background to current

More information

FLUIMUKAN PLUS 600 mg effervescent tablets

FLUIMUKAN PLUS 600 mg effervescent tablets PACKAGE LEAFLET: INFORMATION FOR THE USER FLUIMUKAN PLUS 600 mg effervescent tablets Acetylcysteine This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for

More information

Q. What are metered-dose inhalers? A. These are devices that dispense medicines directly into the lungs, in the form of a mist or aerosol in a

Q. What are metered-dose inhalers? A. These are devices that dispense medicines directly into the lungs, in the form of a mist or aerosol in a 1 2 Q. What are metered-dose inhalers? A. These are devices that dispense medicines directly into the lungs, in the form of a mist or aerosol in a specific dosage. In an MDI, the medicine is suspended

More information

Leeds West CCG Paediatric asthma project. January 2015-January 2017

Leeds West CCG Paediatric asthma project. January 2015-January 2017 Leeds West CCG Paediatric asthma project. January 2015-January 2017 Aims to raise asthma awareness improve care reduce emergency attendances and unplanned admissions to secondary care for children with

More information

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM

IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM BACKGROUND IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM SUMMARY OF ASSESSMENT AND ITS FINDINGS Colistimethate sodium (colistin sulfomethate sodium) is licensed in the UK to be given

More information

Aerospan (flunisolide)

Aerospan (flunisolide) STRENGTH DOSAGE FORM ROUTE GPID 80mcg/actuation HFA aerosol inhaler w/ Inhaled 35718 8.9 g/canister adapter MANUFACTURER Meda Pharmaceuticals INDICATION Aerospan Inhalation Aerosol is indicated for the

More information

Asthma. The prevalence of asthma has been increasing worldwide, but why this is happening is not known.

Asthma. The prevalence of asthma has been increasing worldwide, but why this is happening is not known. Asthma What is asthma? Asthma is a chronic disorder of the airways of the lungs. The airways are reactive and may be inflamed even when symptoms are not present. The extent and severity of airway irritation

More information

paracetamol Please read this leaflet carefully before you are given Paracetamol BNM.

paracetamol Please read this leaflet carefully before you are given Paracetamol BNM. 1 Consumer Medicine Information paracetamol 1000 mg/100 ml solution for injection What is in this leaflet Please read this leaflet carefully before you are given. This leaflet answers some common questions

More information

Transforming asthma services as part of everyday healthcare in Lambeth and Southwark Dr Azhar Saleem GP lead Integrated Respiratory team

Transforming asthma services as part of everyday healthcare in Lambeth and Southwark Dr Azhar Saleem GP lead Integrated Respiratory team 2 12 Transforming asthma services as part of everyday healthcare in Lambeth and Southwark Dr Azhar Saleem GP lead Integrated Respiratory team Transforming London s health and care together 1 Transforming

More information

Update on the IATT Paediatric Formulary. WHO/UNAIDS Consultation with manufacturers March 2015, Geneva, Switzerland

Update on the IATT Paediatric Formulary. WHO/UNAIDS Consultation with manufacturers March 2015, Geneva, Switzerland Update on the IATT Paediatric Formulary WHO/UNAIDS Consultation with manufacturers March 2015, Geneva, Switzerland Summary The Challenge Rationale for Paediatric ARV Formulary Optimization 2015 Revised

More information

Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital

Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital 2014 1 OBJECTIVES Role of the pharmacist s understanding of dysphagia To highlight

More information

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS by: j. jayasutha lecturer department of pharmacy practice Srm college of pharmacy srm university DRUG CHARACTERIZATION: Pre-formulation studies will attempt

More information

Opinion 18 December 2013

Opinion 18 December 2013 The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 18 December 2013 LANTUS 100 units/ml, solution for injection in a vial B/1 vial of 10 ml (CIP: 34009 359 464 9 2)

More information

How we make you feel at ease during a hearing test at

How we make you feel at ease during a hearing test at How we make you feel at ease during a hearing test at Hearology is an ear care company We understand that the prospect of confirming hearing loss is not a very palatable one, and the prospect of having

More information

nisterine Medications

nisterine Medications nisterine Medications Pharmacology for Health Careers sixth edition Donna F. Gauwitz, R.N., M.S. Nursing Consultant Former Senior Teaching Specialist School of Nursing University of Minnesota Minneapolis,

More information

Acute Respiratory Infections

Acute Respiratory Infections T e c h n i c a l S e m i n a r s Acute Respiratory Infections Sensivity & specificity Definition Pneumonia Recognition Fast breathing Antibiotics Severe Pneumonia or Very Severe Disease Lower chest wall

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Dosage Delivery Devices for OTC Liquid Drug Products DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this

More information